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Abstract
Background: Acute cholangitis is a life-threatening bacterial infection of the biliary tract. Main focus of this study
was to create a useful risk prediction model that helps physicians to assign patients with acute cholangitis into
different management groups.
Methods: 981 cholangitis episodes from 810 patients were analysed retrospectively at a German tertiary center.
Results: Out of eleven investigated statistical models fit to 22 predictors, the Random Forest model achieved the best
(cross-)validated performance to predict mortality. The receiver operating characteristics (ROC) curve revealed a mean
area under the curve (AUC) of 91.5 %. Dependent on the calculated mortality risk, we propose to stratify patients with
acute cholangitis into a high and low risk group. The mean sensitivity, specificity, positive and negative predictive value
of the corresponding optimal cutpoint were 82.9 %, 85.1 %, 19.0 % and 99.3 %, respectively. All of these results emerge
from nested (cross-)validation and are supposed to reflect the model’s performance expected for external data. An
implementation of our risk prediction model including the specific treatment recommendations adopted from the
Tokyo guidelines is available on http://www2.imse.med.tum.de:3838/.
Conclusion: Our risk prediction model for mortality appears promising to stratify patients with acute cholangitis into
different management groups. Additional validation of its performance should be provided by further prospective
trails.
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Background
Acute cholangitis is a life-threatening bacterial infec-
tion of the biliary tract ranging from mild symptoms
such as fever and/or chills, abdominal pain and jaun-
dice to septic shock [1–5]. In general, an obstruction
of the biliary system results in a disruption or a reduc-
tion of the bile flow into the duodenum and leads to a
biliary stasis. Bacteria reach the biliary system either
by ascent from the intestine or by the portal venous
system [1]. Inside this biliary stasis the bacteria can
multiply to a great extent [1]. Furthermore, the biliary
stasis leads to an increased intrabiliary pressure with cho-
langiovenous reflux and bacteraemia [1]. The most com-
mon cause of cholangitis is choledocholithiasis [5, 6]. The
key elements of therapy in acute cholangitis are adequate
antimicrobial treatment to avoid or manage septic compli-
cation and biliary decompression to restore biliary drain-
age in case of obstruction [3, 6]. In severe cholangitis, an
early interventional approach is absolutely essential for
survival [3]. However, cholangitis manifests from a broad
variety of causes and with varied severity and therefore
many factors might have an influence on the survival in
patients with acute cholangitis [4]. Major aim of the study
was to create a feasible risk model for predicting mortality
in patients with acute cholangitis, giving the physicians an
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orientation how fast biliary decompression has to be per-
formed and how potent antimicrobial treatment should
be. In the present study, the mortality rate of patients with
acute cholangitis was analysed and related to clinical, la-
boratory and etiological factors.
Methods
Study population
All patients were admitted to the II. Medizinische
Klinik und Poliklinik, Klinikum rechts der Isar,
Technische Universität München. All patients in-
cluded to the study had definitive cholangitis accord-
ing to the Tokyo guidelines 2013 (TG13). Patients
were recruited as follows: First, our clinical endo-
scopic database was queried for patients who under-
went an endoscopic retrograde cholangiography (ERC)
or a percutaneous transhepatic cholangiography
(PTC). Then, clinical indications for the endoscopic or
percutaneous procedures were clarified. For inclusion to
the study, all patients underwent endoscopic retrograde
cholangiography (ERC) or percutaneous transhepatic
cholangiography (PTC) due to biliary obstruction. Patients
had to present elevated temperature (temp > 38 °C) and/
or elevated infection parameters (leukocytes > 12 G/L
and/or C-reactive protein > 3 mg/dL) as well as elevated
cholestasis parameters (1.5 times of the upper limit of the
normal range in bilirubin and/or 2.5 times of the upper
limit of the normal range in γ-glutamyltransferase and/or
2.5 times of the upper limit of the normal range in alkaline
phosphatase). Data collection and analysis of patients with
incomplete data records (missing laboratory values or
medical examination), end stage liver cirrhosis as well as
other focus of infection was not performed. 13 patients
died due to other causes than cholangiosepsis and were
excluded from the study. These patients died either from
end-stage malignancy or complications such as bleeding.
Assessment of predictors for mortality in univariate
analysis
Definition of organ failure was mainly based on the
Tokyo guidelines [3]. One of the following criteria
needed to be fulfilled: hypotension requiring catechol-
amine, serum creatinine > 2 mg/dl, quick’s value < 50
%, platelet count < 100.000 /mm3 and disturbance of
consciousness. Age was dichotomised in two ways,
patients ≥ 65 years of age and patient’s ≥ 75 years of
age. The chronological age of ≥ 65 years is a well-
accepted definition of elderly or older person in medi-
cine [7–10]. The dichotomisation of age (≥75 years)
and other predictors like fever (temperature ≥ 39 °C),
hyerbilirubinemia (≥5 mg/dL) were derived from the
Tokyo guidelines [3].
Statistical analysis
Data analysis was performed with the statistical analysis
tool R 3.1.0 (R Foundation for Statistical Computing,
Vienna, Austria).
Univariate analysis
Fisher’s Exact test was used to investigate the association
of binary and dichotomized predictor variables to in-
hospital mortality. Corresponding Odds Ratios and 95 %
confidence intervals are presented. All statistical tests
were performed on an exploratory, two-sided 5 % signifi-
cance level.
Multivariate analysis
Eleven statistical models were investigated to find the
one that predicts mortality best. The models were 1)
logistic regression with stepwise variable selection
based on Akaike’s Information Criterion (AIC) [11], 2)
logistic regression with stepwise variable selection
based on the Bayesian Information Criterion (BIC)
[11], 3) cross-validated generalized linear models with
L2 (ridge) penalties [12], 4) cross-validated generalized
linear models with L1 (lasso) penalties [12], 5) gradi-
ent boosting with component-wise linear models [13],
6) conditional inference classification trees [14], 7)
conditional inference Random Forest [15], 8) condi-
tional inference Random Forest with test-based vari-
able selection [16, 17], 9) conditional inference
Random Forest with test-based variable selection and
Bonferroni adjustment for multiple testing [16, 17],
10) gradient boosting with regression trees [13], 11)
support vector machines (SVM) with parameters
tuned by cross-validation [18].
These model were fit to the following 22 predictors:
 Age as continuous variable
 Age as dichotomised (age ≥ 65) variable
 Age as dichotomised (age ≥ 75) variable
 Temperature as continuous variable
 Temperature as dichotomised (temperature ≥ 39 °C)
variable
 Leucocytes as continuous variable
 Leucocytes as dichotomised variable (leucocytes >
15 G/l)
 Bilirubin as continuous variable
 Bilirubin dichotomised (bilirubin ≥ _5 mg/dl)
variable
 Quick’ s value as continuous variable
 Quick’ s value as dichotomised (quick’s value < 50 %)
variable
 Serum creatinine as continuous variable
 Serum creatinine as dichotomised (serum
creatinine ≥ 2 mg/dl) variable
 Platelet count as continuous variable
Schneider et al. BMC Gastroenterology  (2016) 16:15 Page 2 of 8




 Previous cholangitis episode
 Previous intervention (ERC/PTC)
 Hypotension requiring catecholamine
 Underlying cause of cholangitis (malignant/non-
malignant)
As we seek to identify the model that will perform best
on external data and as we would like to learn about its
expected predictive performance, there needs to be a val-
idation. In a data-rich situation the data is simply split into
three parts, a training set, a validation set and a test set
[19]. The models are fit to the training set and applied to
the validation set to identify the best model. This best
model is then applied to the test set to assess the perform-
ance it can achieve on unseen data. As we are not in a
data-rich situation, nested five-fold cross-validation with
an internal and external loop was applied alternatively.
Here the data is split into five parts. Each part serves as a
test set for a model found to perform best on the
remaining four parts of the data (= external cross-
validation loop). The latter parts are again split into five
parts, each one makes up a validation set while the
remaining four are used as training set (= internal cross-
validation loops). The performance of the best models
found in the internal cross-validation loops can then be
computed on the test data of the external cross-validation
loop. This is the performance that can be expected for the
application of a best model to unseen data (= model as-
sessment). The best model itself is determined on the ex-
ternal cross-validation loop (= model selection). It is
finally fit to the entire data to use all of the information
available for learning.
The optimal cutpoints used to categorize patients into a
high and low risk group were defined to be the ones maxi-
mising the Youden-Index = Sensitivity + Specificity – 1.
They were computed within the external cross-validation
loop, as the test sets of the data were omitted. Estimates
for sensitivity, specificity, positive predictive value and




981 acute cholangitis episodes from 810 patients were
included to the study. Median age was 68 years (range
24 – 97 years). Underlying causes for acute cholangitis
are illustrated in Table 1. In most cases, acute cholan-
gitis was due to malignant diseases. All patients under-
went either endoscopic retrograde cholangiography or
percutaneous transhepatic cholangiography. PTC was
performed in 310 cholangitis episodes. Overall, mortality
rate was 4.5 %. These patients died due to cholangiosepsis.
Univariate analysis of predictors for mortality
Univariate analysis of different predictors is illustrated in
Table 2. Organ failure showed by far the strongest asso-
ciation with mortality [P < 0.001, Odds Ratio (OR): 47.1,
95 % confidence interval (95 % CI): (14.3 -155.1)].
Among predictors contributing to organ failure, the high-
est OR was observed for mental confusion [P < 0.001, OR:
37.6, 95 %-CI: (16.7 - 84.9)], followed by hypotension
requiring catecholamine [P < 0.001, OR: 7.7, 95 %-CI: (3.6-
16.5)], quick’s value < 50 % [P < 0.001, OR: 6.4. 95 %-CI:
(2.9 - 14.5)], serum creatinine >2 mg/dl [P = 0.012, OR:
4.3, 95 %-CI: (1.5 - 11.8)] and a platelet count < 100.000
Table 1 Patients’ baseline characteristics
Baseline characteristics
number of patients 810
- median age in years (range) 68(27-97)
- male 456
number of cholangitis episodes 981





- pancreas cancer 162
(16,5 %)
- hepatocellular carcinoma 7 (0,7 %)
- liver metastases with intrahepatic
biliary obstruction:
o colorectal cancer 50 (5,1 %)
o gastric cancer 30 (3,1 %)
o gallbladder cancer 28 (2,9 %)
o other malignant tumors




- stricture of the biliodigestive anastomosis 32 (3,3 %)
- chronic pancreatitis with extrahepatic biliary
obstruction
17 (1,7 %)
- bile duct stricture after cholecystectomy 36 (3,7 %)
- liver cyst with intrahepatic biliary stricture 1 (0,1 %)
- adenoma of the papilla vateri 6 (0,6 %)
- choledocholithiasis 271
(27,6 %)
- primary sclerosing cholangitis 21 (2,1 %)
- trauma associated strictures 6 (0,6 %)
- secondary sclerosing cholangitis 1 (0,1 %)
idiopathic biliary stricture: 81 (8,3 %)
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Table 2 Univariate analysis of binary and dichotomized risk predictors
Univariate analysis of binary and
dichotomized risk predictors
Incidence of mortality [Odds ratio (95 %-CI)] P- value
age≥ 65 4.0 %(23/579) [1.1(0.5-2.3)] P = 0.736
age < 65 3.5 %(14/402)
age≥ 75 4.3 %(13/303) [1.2(0.6-2.5)] P = 0.588
age < 75 3.5 %(24/678)
male 2.9 %(16/549) [1.7(0.8-3.4)] P = 0.129
female 4.9 %(21/432)
fever (temp ≥39 °C) 3.8 %(2/52) [1.0(0.2-4.4)] P = 1.000
fever (temp <39 °C) 3.8 %(34/905)
previous episode of cholangitis 3.8 %(17/446) [1.0(0.5-1.9)] P = 1.000
no previous cholangitis episode 3.7 %(20/535)
indwelling stent (stent therapy) 3.4 %(16/466) [0.8(0.4-1.7)] P = 0.619
no indwelling stent (stent therapy) 4.1 %(21/515)
PTC as interventional approach 6.1 %(19/310) [2.4(1.2-4.6)] P = 0.011
no PTC as interventional approach 2.7 %(18/671)
mental confusiona 25.9 %(29/112) [37.6(16.6-85.0)] P < 0.001
no mental confusion 0.9 %(8/869)
previous intervention (ERC/PTC) 5.0 %(19/383) [0.6(0.3-1.2)] P = 0.125
no previous intervention 3.0 %(18/598)
hypotension requiring catecholaminea 18.3 %(11/60) [7.7(3.6-16.6)] P < 0.001
no hypotension requiring catecholamine 2.8 %(26/921)
insufficient drainage 8.3 %(20/240) [4.5(2.2-9.1)] P < 0.001
adequate drainage 2.0 %(14/706)
organ failure including all parameters witha 15.7 %(34/217) [47.1(14.3-155.2)] P < 0.001
no organ failure 0.4 %(3/764)
leucocytes > 15 G/l 6.9 %(12/174) [2.3(1.1-4.8)] P = 0.026
leucocytes≤ 15 G/L 3.1 %(25/807)
bilirubin ≥5 mg/l 6.4 %(29/452) [4.5(2.0-9.9)] P < 0.001
bilirubin <5 mg/l 1.5 %(8/529)
aspartat-Aminotransferase (AST) > 70 5.3 %(19/357) [2.1(1.0-4.3)] P = 0.046
aspartat-Aminotransferase (AST)≤ 70 2.6 %(14/532)
alanin-Aminotransferase (ALT) > 70 3.0 %(14/462) [0.7(0.3-1.3)] P = 0.242
alanin-Aminotransferase (ALT)≤ 70 4.6 %(23/502)
quick’s value < 50 % 16,7 %(9/54) [6.4(2.8-14.5)] P < 0.001
quick’s value≥ 50 % 3.0 %(28/927)
serum creatinine >2 mg/dla 13.2 %(5/38) [4.3(1.5-11.8)] P = 0.012
serum creatinine≤ 2 mg/dl 3.4 %(32/943)
platelet count < 100.000/mm3a 9.8 %(5/51) [3.0(1.1-8.2)] P = 0.038
platelet count≥ 100.000/mm3 3.4 %(32/930)
bacteremia 7.7 %(14/182) [2.8(1.4-5.6)] P = 0.004
no bacteremia 2.9 %(23/799)
malignant genesis 1.9 %(9/472) [3.0(1.3-6.5)] P = 0.004
non malignant genesis 5.5 %(28/509)
aparameters included to organic failure
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/mm3 [P < 0.038, OR: 3.0, 95 %-CI: (1.1- 8.2)] before a
treatment was initiated. In addition, a bilirubin level ≥
5 mg/dl [P < 0.001, OR: 4.5, 95 %-CI: (2.2 - 9.9)], leuco-
cytes ≥ 15 g/l [P = 0.026, OR: 2.3, 95 % CI: (1.1 - 4.7)], the
presence of bacteraemia[P = 0.004, OR: 2.8, 95 %-CI: (1.4 -
5.6)], insufficient drainage [P < 0.001, OR 4.5, 95 %-CI:
(2.2-9.1)], aspartat-Aminotransferase (AST) > 70 [P =
0.046,OR 2.1, 95 %-CI: (1.0-4.3)] and PTC as therapeutic
approach [P = 0.011, OR: 2.4, 95 %-CI: (2.2 - 9.0)]
were also significantly associated with a higher mor-
tality rate. Concerning etiological factors, patients
with a malignant underlying disease had also a higher
incidence of mortality compared to patients with an
idiopathic or benign underlying disease for cholangitis
[P = 0.001, OR: 3.0, 95 %-CI: (1.4 - 6.4)]. A direct
comparison of risk predictors by the OR is possible
in this case as they are measured on the same scale,
i.e., they are binary or dichotomized.
Multivariate risk prediction model for in-hospital
mortality
Only predictors that are ,in general, easily to assess at the
time point of hospital admission were used for the multi-
variate risk prediction model including the predictors
“creatinine”, “mental confusion”, “bilirubin”, “leucocytes”,
“temperature”, “platelet count”, “sex”, “previous cholan-
gitis episodes”, “previous intervention (ERC/PTC)”, “age“,
“hypotension requiring catecholamine”, “quick’s value”
and “underlying disease”. These 13 predictors have been
dichotomized using several established cutpoints and
combined to produce further information. In summary,
22 risk predictors were created, which are listed in the
statistical analysis section.
Eleven statistical prediction models were evaluated
and (cross-)validated revealing the best prediction per-
formance for the Random Forest model. This choice
leads to some conclusions: There might be non-linear
effects and complex relations among predictors which
cannot be coped, e.g., with the application of regression
models in their basic form. The logistic regression
model, for example, led to a decisively worse prediction
performance. As all of the models that use variable se-
lection were also inferior, it can be concluded that each
predictor has a certain predictive value and is able to
beneficially contribute to the prediction model.
The predictive performance of the Random Forest pre-
diction model was measured by ROC analysis which re-
sulted in a mean AUC of 91.5 %. Fig. 1 illustrates the
range of ROC curves of the five (cross-)validation steps.
The corresponding AUC values were 84.4 %, 89.3 %,
93.1 %, 93.5 % and 96.9 %. The optimal cut-off point, de-
fined by the maximal Youden-Index, is the predicted
mortality risk of 0.7 %. The corresponding mean sensi-
tivity and specificity were 82.9 % (computed from the
five cross-validated values 71.4 %, 71.4 %, 85.7 %, 85.7 %
and 100 %) and 85.1 % (computed from the values
78.0 %, 82.5 %, 84.1 %, 87.4 % and 93.4 %). Furthermore,
the mean positive predictive and negative predictive
values of the cut-point were 19 % (computed from
14.9 %, 15.8 %, 17.1 %, 17.9 %, 29.4 %) and 99.3 % (com-
puted from 99.3 %, 99.4 %, 98.8 %, 98.8 %, 100 %). In-
stead of the mean values one could also chose to use the
worst performance values for a conservative assessment
of the model.
Proposed treatment algorithm for prospective evaluation
Based on the optimal cut-off value (0.7 %) of the predic-
tion model, patients were classified into a high risk and
a low risk group (Fig. 2). Referring to the Tokyo guide-
lines [20], the low risk group was further subdivided into
acute cholangitis with a mild (grade I) and a moderate
(grade II) grade of severity. According to the Tokyo
guidelines, moderate grade of severity applies if any two
of the following conditions are fulfilled: Leucocyte >
12 G/l or < 4 G/l, high fever ≥ 39 °C, age ≥ 75 years, bili-
rubin ≥ 5 mg/dl. Thus, acute cholangitis of the low risk
group, which do not fulfil the above mentioned criteria
for moderate grade (II) of severity are defined as acute
cholangitis with a mild (I) grade of severity. Dependent
on the risk groups, the following treatment recommen-
dation are proposed:
Low risk mortality group
Elective biliary drainage is recommended for acute chol-
angitis with a mild grade of severity (according to the
Tokyo guidelines). In case of acute cholangitis with a
moderate grade of severity (according to the Tokyo
guidelines), early biliary (within 24 h) drainage should be
performed
High risk mortality group
Urgent biliary drainage is recommended for patients
with a high predicted mortality risk. Dependent on the
level of mortality risk, biliary drainage should be per-
formed either immediately or within a narrow time
frame (within hours).
In all three groups, immediate initiation of antimicro-
bial treatment is recommended. The use of broad
spectrum antibiotics should be adapted to the local re-
sistance situation, the individual risk for multi-resistant
bacteria and to the individual predicted mortality risk.
Implementation
Due to its elaborateness, it is not possible to put the predic-
tion model to paper. Therefore, the risk prediction model is
available online on http://www2.imse.med.tum.de:3838/.
After the user has made his choices for the risk predictors,
an individual risk prediction, the membership to a certain
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risk group and a treatment recommendation is returned for
the patient.
Discussion
Adequate management of acute cholangitis is essential
for survival [21–24]. However, acute cholangitis mani-
fests from a broad variety of causes and with varied se-
verity. Therefore, risk stratification in patients with
acute cholangitis for increased mortality seems to be
reasonable, allowing a differentiated antimicrobial and
interventional treatment. In literature, the Tokyo guide-
lines provide international standards for diagnostic and
severity assessment criteria [3] and consider organ dys-
function as the most common predictor of poor out-
come. According to the Tokyo guidelines [3], acute
cholangitis should be classified into three grades of se-
verity (Grade I – III). A disadvantage of TG13 is that
Patients are equally weighted within the respective
severity groups, regardless of the number and type of ful-
filled predictors. For example, TG13 does not differentiate
between the type and number of organ failures. However,
our data strongly suggest that the type of organ failure
should be weighted differently for predicting mortality. In
the univariate analysis of binary and dichotomized risk
predictors, mental confusion was the strongest predictor,
compared to renal, liver or haematological disorders. Dis-
turbance of consciousness was also reported to be a well
predictor for an increased mortality in other infections
like community acquired pneumonia [25]. Similar to our
data, mental confusion was associated with the highest
risk for mortality in an international validation study [25],
assessing the severity of pneumonia: The odds for mortal-
ity in patient with mental confusion was 8 times higher
compared to patients without mental confusion [OR: 8.1,














Fig. 1 Range of the receiver operating characteristic (ROC) curves obtained by five-fold cross-validation. The mean AUC is 91.5 %. The rhomb
indicates the mean performances of the optimal cutpoint
Figure 2 Recommended treatment algorithm based on the calculated mortality risk
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predictors like respiratory rate > 30/min, low systolic
blood pressure < 90 mmhg , urea > 7 mmol/l, albumin <
30 g/dl had odds ratios (95 %-CI) of 1.7(1.1 - 2.8), 2.4(1.4 -
3.8), 5.6(3.1 - 10), 4.9(2.8 - 8.4), respectively. Furthermore,
TG 13 uses only dichotomized laboratory parameters.
Therefore, TG13’s severity assessment is similar irrespect-
ive of whether laboratory parameters differ strongly or
only marginally from the determined cut off value. Our
prediction model considers patients with strongly or only
marginally deviating laboratory parameters differently. To
the best of our knowledge, this is the first prediction
model for adapting the treatment of acute obstructive
cholangitis to the individual calculated mortality risk. In
contrast to TG13, the individual mortality risk is assessed
by using 22 continuous and dichotomized predictors. Pa-
tients are classified into a high risk and a low risk group,
based on the optimal cut-off point (mortality risk of
0.7 %). Consequently, patients with a mild or moderate
cholangitis according to TG13 are assigned to the high
risk group, if the predicted mortality risk is 0.7 % or
higher.
Occurrence of bacteraemia was also significantly associ-
ated with a higher mortality rate, stressing the importance
of blood culture collection in patient with acute cholan-
gitis, so that empirical antimicrobial treatment can be op-
timized in cases of bacteraemia. However, bacteraemia is
not a good parameter to evaluate at the time point of hos-
pital admission. In clinical practice it is not possible to
diagnose bacteraemia immediately at the time point of
hospital admission, because the current microbiological
analysing methods used to detect pathogens in blood cul-
tures still create a delay of at least one day. Major focus of
the study was to create a risk prediction model that is easy
to perform at the time point of hospital admission. There-
fore, the predictor “bacteraemia” as well the predictor
“PTC as interventional approach” were excluded from the
model. Despite the exclusion of these two predictors, the
AUC of the final model was excellent. Referring to the op-
timal cut-point, which is a predicted mortality risk of
0.7 %, the corresponding negative predictive value of the
risk prediction model shows that it performs particularly
well when it comes to the identification of patients that
will survive. The positive predictive value is much lower
which means that only a small fraction among the patients
that are assigned a high mortality risk by the model will
actually die. In the clinical setting and from a patient
perspective such properties are beneficial as, firstly, the
mortality rate in the low risk group is actually low. Conse-
quently there is almost no danger of having high risk
patients in this group. Secondly, the high risk group is
defined wide enough to include all of the real high risk
patients which is reflected by a high sensitivity. This
comes at the expense of the inclusion of some patients
with actual low risk, of course.
It is reasonable to triage patients with acute cholan-
gitis according to their individual mortality risk. On the
one hand, emergency interventions outside the routine
operations are resource intensive and choice of anti-
microbial agents, in particular reserve antibiotics should
be selected with care in the face of increasing antimicro-
bial resistance development [26, 27]. On the other hand,
early biliary decompression to restore biliary drainage
and the administration of an effective antimicrobial
treatment are essential for survival in patients with sep-
tic shock [20, 28]. Consequently, a feasible prediction
model helping physicians to determine the time point of
intervention and the choice of antimicrobial agents upon
the patient’s risk for mortality would be desirable. Refer-
ring to the individual mortality risk calculated by our
prediction model, we recommend urgent biliary drainage
for patients with a high predicted mortality risk. In con-
trast, elective drainage may be appropriate for patients
with a low predicted mortality risk presenting a mild
grade of severity as we could show that the negative pre-
dictive value of our prediction model is very high. The
proposed cut-point helps to allocate patients to a high
and low risk group. However, this treatment algorithm
requires prospective evaluation.
The strength of this study lies in the large sample size
and the broad spectrum of clinical, laboratory, etiological
factors which were evaluated. Major limitations of the
study are its retrospective nature and single centre char-
acter, which limits the extrapolation of our data to other
centres, although nested cross-validation was performed.
A further limitation is that only the in-hospital mortality
and not the 30 days mortality was assessed.
Conclusion
Out of eleven investigated statistical models, a Random
Forest model achieved excellent prediction performance
(measured by AUC) and is provided online (http://
www2.imse.med.tum.de:3838/) for individual risk predic-
tion. Based on the predicted risk for mortality, we
propose a simple treatment algorithm. However, this
model requires prospective evaluation by multi-center
studies.
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